Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,896 public trials 1,789 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795

NCT00920257

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +21 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer

NCT01669239

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital Universitario Vall d´Hebron Barcelona, Spain
  • Complejo Hospitalario San Pedro de Alcántara Cáceres, Spain
  • Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain
View all 19 locations
View Trial Details
Completed

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer

NCT01669252

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Institut Gustave Roussy Villejuif, France
  • Brustzentrum im Krankenhaus Köln-Holweide Priv. Doz. Cologne, Germany
  • Klinikum des Landkreises Deggendorf Frauenklinik Mammazentrum Deggendorf, Germany
  • Brustzentrum der Universität München Munich, Germany
View all 30 locations
View Trial Details
Completed

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

NCT00382018

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • NEA Medical Center - Stadium Boulevard Jonesboro, Arkansas, United States
View all 296 locations
View Trial Details
Completed

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

NCT02556632

Conditions
Breast Carcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Delaware/Christiana Care NCORP Newark, Delaware, United States
  • Heartland NCORP Decatur, Illinois, United States
  • Metro-Minnesota NCORP Minneapolis, Minnesota, United States
  • University of Rochester Rochester, New York, United States
View Trial Details

Related conditions